Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Orgenesis Inc's (OTC: ORGS) North America CEO Scott Carmer in August gave the fight against diabetes a personal touch.
"As the father of a child who is living with Type 1 diabetes, I am personally motivated to help bring the innovative science pioneered by the Orgenesis team into the clinic."
Carmer’s personal motivation spoke to Orgenesis’ primary goal –- finding a cure for Type 1 diabetes.
Moreover, the company said it believed that goal was attainable thanks to the hard work of the Orgenesis research team led by Dr. Sarah Ferber.
http://www.benzinga.com/news/14/11/4969408/how-orgenesis-hopes-to-cure-type-1-diabetes
"As the father of a child who is living with Type 1 diabetes, I am personally motivated to help bring the innovative science pioneered by the Orgenesis team into the clinic."
Carmer’s personal motivation spoke to Orgenesis’ primary goal –- finding a cure for Type 1 diabetes.
Moreover, the company said it believed that goal was attainable thanks to the hard work of the Orgenesis research team led by Dr. Sarah Ferber.
http://www.benzinga.com/news/14/11/4969408/how-orgenesis-hopes-to-cure-type-1-diabetes